Erythrocyte-Platelet Hybrid Membrane Coating for Enhanced Nanoparticle Functionalization

Area of Science:

• Biomaterials Science
• Nanotechnology
• Cell Biology

Background:

• Cell-membrane-coated nanoparticles offer excellent biocompatibility and cellular property retention.
• Existing nanoparticles utilize single cell membranes (e.g., RBCs, platelets, cancer cells) for specific functionalities.
• There is a need for enhanced nanoparticle platforms with tailored, multi-functional properties.

Purpose of the Study:

• To develop a novel method for creating dual-membrane-coated nanoparticles by fusing cell membranes.
• To demonstrate the creation and characterization of red blood cell-platelet hybrid membrane-coated nanoparticles ([RBC-P]NPs).
• To evaluate the potential of these hybrid nanoparticles for therapeutic and imaging applications.

Main Methods:

• Fabrication of nanoparticles coated with fused red blood cell (RBC) and platelet membranes.
• Characterization of the resulting dual-membrane-coated nanoparticles ([RBC-P]NPs).
• Assessment of the hybrid nanoparticles' properties and in vivo circulation potential.

Main Results:

• Successfully developed dual-membrane-coated nanoparticles ([RBC-P]NPs) from fused RBC and platelet membranes.
• Demonstrated that [RBC-P]NPs possess characteristics of both parent cell types.
• Observed long circulation times and suitability for in vivo studies with the [RBC-P]NP platform.

Conclusions:

• The fusion of distinct cell membranes provides a facile strategy to create enhanced biomimetic nanoparticles.
• [RBC-P]NPs exhibit hybrid functionalities, offering a promising platform for overcoming limitations in current nanomedicine.
• This approach enables the development of custom-tailored nanoparticles with diverse hybrid functionalities for advanced applications.